Full Text | PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

J Cancer 2015; 6(7):610-615. doi:10.7150/jca.11710 This issue Cite

Research Paper

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative

Nisreen Elsayegh1, Jessica Profato1, Angelica M. Gutierrez Barrera2, Heather Lin3, Henry M. Kuerer4, Can Ardic2, Jennifer K. Litton2, Debasish Tripathy2, Banu K. Arun1,2 ✉

1. Clinical Cancer Genetics, the University of Texas MD Anderson Cancer Center, Houston, TX
2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX
3. Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, TX
4. Department of Surgical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX

✉ Corresponding author: Banu K. Arun, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1354, Houston, TX 77030-4009. e-mail: barunorg; Tel: (713) 792-2817; Fax: (71 More

Citation:
Elsayegh N, Profato J, Barrera AMG, Lin H, Kuerer HM, Ardic C, Litton JK, Tripathy D, Arun BK. Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative. J Cancer 2015; 6(7):610-615. doi:10.7150/jca.11710. https://www.jcancer.org/v06p0610.htm
Other styles

File import instruction

Abstract

The authors retrospectively examined the contralateral prophylactic mastectomy (CPM) rate among 100 women with ductal carcinoma in situ who are BRCA negative. Of 100 women with ductal carcinoma in situ, 31 elected contralateral prophylactic mastectomy (CPM). Factors associated with increased likelihood of undergoing contralateral prophylactic mastectomy (CPM) among this cohort were: family history of ovarian cancer, marital status, reconstruction, mastectomy of the affected breast, and tamoxifen use.

Keywords: contralateral prophylactic mastectomy, BRCA negative

Citation styles

APA
Elsayegh, N., Profato, J., Barrera, A.M.G., Lin, H., Kuerer, H.M., Ardic, C., Litton, J.K., Tripathy, D., Arun, B.K. (2015). Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative. Journal of Cancer, 6(7), 610-615. https://doi.org/10.7150/jca.11710.

ACS
Elsayegh, N.; Profato, J.; Barrera, A.M.G.; Lin, H.; Kuerer, H.M.; Ardic, C.; Litton, J.K.; Tripathy, D.; Arun, B.K. Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative. J. Cancer 2015, 6 (7), 610-615. DOI: 10.7150/jca.11710.

NLM
Elsayegh N, Profato J, Barrera AMG, Lin H, Kuerer HM, Ardic C, Litton JK, Tripathy D, Arun BK. Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative. J Cancer 2015; 6(7):610-615. doi:10.7150/jca.11710. https://www.jcancer.org/v06p0610.htm

CSE
Elsayegh N, Profato J, Barrera AMG, Lin H, Kuerer HM, Ardic C, Litton JK, Tripathy D, Arun BK. 2015. Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative. J Cancer. 6(7):610-615.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2025 Ivyspring International Publisher. Terms of use